Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review
- DOI
- 10.1186/s12931-025-03360-0
- Published
- 2025-10-29
- Container
- Respiratory Research
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12931-025-03360-0,
title = {Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review},
author = {Steven G. Kelsen and Marcus Maurer and Michael Waters and Ajit Dash and Alice Fong and Divya Mohan and Wiebke Theess and Xiaoying Yang and Giuseppe Alvaro and Christopher E. Brightling},
year = {2025},
journal = {Respiratory Research},
doi = {10.1186/s12931-025-03360-0},
url = {https://doi.org/10.1186/s12931-025-03360-0}
}RIS
TY - JOUR TI - Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review AU - Steven G. Kelsen AU - Marcus Maurer AU - Michael Waters AU - Ajit Dash AU - Alice Fong AU - Divya Mohan AU - Wiebke Theess AU - Xiaoying Yang AU - Giuseppe Alvaro AU - Christopher E. Brightling PY - 2025 JO - Respiratory Research DO - 10.1186/s12931-025-03360-0 UR - https://doi.org/10.1186/s12931-025-03360-0 ER -
APA
Kelsen, S. G., Maurer, M., Waters, M., Dash, A., Fong, A., Mohan, D., Theess, W., Yang, X., Alvaro, G., & Brightling, C. E. (2025). Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review. Respiratory Research. https://doi.org/10.1186/s12931-025-03360-0
Source records
- crossref · retrieved 2026-09-26T21:48:43.171Z